Enfortumab Vedotin Plus Pembrolizumab With Selective Bladder Sparing for Treatment of Muscle-invasive Bladder Cancer — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(5 sites)
United States
City of Hope, Duarte, California Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana Icahn School of Medicine at Mount Sinai, New York, New York Columbia University Irving Medical Center, New York, New York Fox Chase Cancer Center, Philadelphia, Pennsylvania Last updated February 2026